Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 15 - Issue 5 - May, 2003

Feature

Case Report
Subacute Development of a Coronary Artery Pseudoaneurysm After Primary Angioplasty and Stenting for Acute Myocardial Infarction
08/01/2008
Camille Brasselet, MD, Sophie Pérotin, MS, *Jean-Francois Fuzellier, MD
Camille Brasselet, MD, Sophie Péroti...
The pharmacological and mechanical coronary angioplasty environment extensively enhances the immediate outcome so much that acute procedural complications seem to belong to the past. Other than restenosis, the management of which is now well...
The pharmacological and mechanical coronary angioplasty environment extensively enhances the immediate outcome so much that acute procedural complications seem to belong to the past. Other than restenosis, the management of which is now well...
The pharmacological and...
08/01/2008
Journal of Invasive Cardiology
Practice Management and Economics
Heart Center Implementation and Start-Up: The Parma Community General Hospital Experience
08/01/2008
Ron Schmidt
Ron Schmidt
Just over three years ago, the President and CEO of Parma Community General Hospital (PCGH) and his administrative team decided to expand the cardiovascular service line to include open-heart surgery (OHS) and interventional cardiac...
Just over three years ago, the President and CEO of Parma Community General Hospital (PCGH) and his administrative team decided to expand the cardiovascular service line to include open-heart surgery (OHS) and interventional cardiac...
Just over three years ago, the...
08/01/2008
Journal of Invasive Cardiology
Practice Management and Economics
Breaking Some of the Rules
08/01/2008
Ronald N. Riner, MD
Ronald N. Riner, MD
The article on the One Stop Post Op Unit in this issue points to a rather innovative way of taking care of postoperative patients. Peter Drucker, one of the more renowned management thinkers of our time, constantly extols the fact that...
The article on the One Stop Post Op Unit in this issue points to a rather innovative way of taking care of postoperative patients. Peter Drucker, one of the more renowned management thinkers of our time, constantly extols the fact that...
The article on the One Stop Post...
08/01/2008
Journal of Invasive Cardiology
Case Report
Premature Coronary Artery Disease in Systemic Lupus Erythematosus with Extensive Reocclusion Following Coronary Artery Bypass Su
08/01/2008
David J. D’Agate, DO, Spyros Kokolis, MD, Nehad Soloman, MD, Elise Belilos, MD, Steven Carsons, MD, Julia Andrieni, MD, Thomas Argyros, MD, Lynne A. Glasser, MD, George Dangas, MD, PhD
David J. D’Agate, DO, Spyros Kokoli...
Advances in medical therapy and a better understanding of systemic lupus erythematosus (SLE) have contributed to a dramatic improvement in the long-term survival of patients. However, despite the overall long-term improvement, coronary artery...
Advances in medical therapy and a better understanding of systemic lupus erythematosus (SLE) have contributed to a dramatic improvement in the long-term survival of patients. However, despite the overall long-term improvement, coronary artery...
Advances in medical therapy and...
08/01/2008
Journal of Invasive Cardiology
Electrophysiology Corner
Results of the Companion Trial — Another Breakthrough in Electrophysiology
08/01/2008
Todd J. Cohen, MD
Todd J. Cohen, MD
Recently, the Companion Trial was terminated via the Safety and Monitoring Board for that trial. This was a breakthrough trial in which patients with moderate to severe congestive heart failure (New York Heart Association class III and IV),...
Recently, the Companion Trial was terminated via the Safety and Monitoring Board for that trial. This was a breakthrough trial in which patients with moderate to severe congestive heart failure (New York Heart Association class III and IV),...
Recently, the Companion Trial...
08/01/2008
Journal of Invasive Cardiology
Electrophysiology Corner
Mechanical Reperfusion of Acute Right Coronary Artery Occlusion After Radiofrequency Catheter Ablation and Long-Term Follow-up A
08/01/2008
Angelo A. de Paola, MD, Luiz R. Leite, MD, Elerson Arfelli, MD
Angelo A. de Paola, MD, Luiz R. Leite...
Radiofrequency catheter ablation (RFCA) has become the most effective and safe method for treating Wolff-Parkinson-White (WPW) syndrome in children and adolescents. Accessory pathways (APs) located in the postero-septal region account for up...
Radiofrequency catheter ablation (RFCA) has become the most effective and safe method for treating Wolff-Parkinson-White (WPW) syndrome in children and adolescents. Accessory pathways (APs) located in the postero-septal region account for up...
Radiofrequency catheter ablation...
08/01/2008
Journal of Invasive Cardiology

Column

Editorial Message
Editor`s Message - March 2003
08/01/2008
Richard E. Shaw, PhD, FACC, Editor-in-Chief
Richard E. Shaw, PhD, FACC, Editor-in...
Dear Readers, This issue of the Journal of Invasive Cardiology, which coincides with the 52nd Annual Scientific Sessions of the American College of Cardiology, includes original research articles, case reports, editorials, articles from the...
Dear Readers, This issue of the Journal of Invasive Cardiology, which coincides with the 52nd Annual Scientific Sessions of the American College of Cardiology, includes original research articles, case reports, editorials, articles from the...
Dear Readers, This issue of the...
08/01/2008
Journal of Invasive Cardiology
Editorial
Carotid Stenting: A Gordian Knot to be Unraveled (Part I of II)
08/01/2008
Gerald Dorros, MD, FACC, ScD (Yeshiva), ScD (Colby)
Gerald Dorros, MD, FACC, ScD (Yeshiva...
Balloons, stents and embolic protection devices, as treatment for extracranial obliterative disease, have created in recent decades a predicament not dissimilar to the percutaneous treatment of coronary angioplasty and mitral valvuloplasty....
Balloons, stents and embolic protection devices, as treatment for extracranial obliterative disease, have created in recent decades a predicament not dissimilar to the percutaneous treatment of coronary angioplasty and mitral valvuloplasty....
Balloons, stents and embolic...
08/01/2008
Journal of Invasive Cardiology
Editorial
Carotid Stenting: A Gordian Knot to be Unraveled (Part II of II)<br />
08/01/2008
Gerald Dorros, MD, FACC, ScD (Yeshiva), ScD (Colby)
Gerald Dorros, MD, FACC, ScD (Yeshiva...
Conclusions. As this nascent period of endovascular carotid procedures draws to an end, what is clear, crystal clear to me, is that a significant conundrum exists. The Gordian knot to be unraveled is not whether stent-supported carotid...
Conclusions. As this nascent period of endovascular carotid procedures draws to an end, what is clear, crystal clear to me, is that a significant conundrum exists. The Gordian knot to be unraveled is not whether stent-supported carotid...
Conclusions. As this nascent...
08/01/2008
Journal of Invasive Cardiology

Insights

Commentary
Letters to the Editor
08/01/2008
Brian Funaki, MD University of Chicago Hospitals Chicago, Illinois. and Alborz Hassankhani, MD, PhD and William F. Penny, MD VA San Diego Healthcare System, San Diego, California.
Brian Funaki, MD University of Chica...
To the Editor: Recently, I have treated a number of patients with functioning dialysis fistulae or synthetic arteriovenous grafts referred for arm swelling developing after pacemaker insertion (Figure A). Invariably, a stenosis or occlusion...
To the Editor: Recently, I have treated a number of patients with functioning dialysis fistulae or synthetic arteriovenous grafts referred for arm swelling developing after pacemaker insertion (Figure A). Invariably, a stenosis or occlusion...
To the Editor: Recently, I have...
08/01/2008
Journal of Invasive Cardiology

Advertisement

Advertisement

Advertisement

News

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death&nbsp; Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death&nbsp; Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest
plaque analysis
HeartFlow Announces New Category I CPT Code from the American Medical Association for AI-Enabled Plaque Analysis to Assess Risk for Coronary Artery Disease
10/18/2024
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance of this upgraded Category I CPT billing code, which validates the technology’s clinical value in quantifying and characterizing plaque to help assess risk and personalize treatment for patients with coronary...
“We commend the AMA’s issuance...
10/18/2024
Cath Lab Digest
Hypertension
New Study Links Obesity to Elevated Hypertension Risk Among Young Middle Eastern Women
10/18/2024
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who are obese or overweight are facing a higher risk for the development of atherosclerotic cardiovascular disease and its associated risk factors like hypertension and Type Two diabetes,” said Mohammad Adnan Bani...
“Young Middle Eastern women who...
10/18/2024
Cath Lab Digest

Advertisement

Advertisement

A study led by researchers from Shinshu University propose a simplified risk-scoring model helps clinicians assess when patients with cardiogenic shock can be safely weaned off from MCS devices, such as VA-ECMO or IMPELLA, using easily measurable health indicators like blood pressure and heart function. Credit Sho Suzuki from Shinshu University
Mechanical Circulatory Support
A Simple Risk Score for Weaning Patients From Mechanical Circulatory Support
10/23/2024
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu University developed a simple risk score model using readily measurable health indicators to predict successful MCS weaning. The study analyzed data from 114 patients.
Researchers from Shinshu...
10/23/2024
Cath Lab Digest
Original Contribution
Intravascular Ultrasound in the Assessment of Coronary Artery Anomalies in Young Patients: A Tertiary Center Experience
10/23/2024
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young population of patients with anomalous aortic origin of a coronary artery and myocardial bridge and review the safety of intravascular ultrasound in this population.
The authors describe a young...
10/23/2024
Journal of Invasive Cardiology
The initial cases with the Luna TMVR System were conducted in Paraguay and the Republic of Georgia and supported by leading US structural heart experts and the Tioga Cardiovascular team.
Mitral Valve intervention
Tioga Cardiovascular Announces First-In-Human Cases With Its Luna Transcatheter Mitral Valve Replacement (TMVR) System
10/23/2024
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a Shifamed portfolio company, announced the first-in-human transseptal implantations using the 28 French) Luna™ transcatheter mitral valve replacement (TMVR) system. The first patients achieved excellent...
Tioga Cardiovascular, Inc., a...
10/23/2024
Cath Lab Digest
Original Contribution
Comparison of Two Vascular Closure Device Strategies for Transfemoral Transcatheter Aortic Valve Replacement Using Suture-Based and Collagen-Plug-Based Techniques and Associated Vascular Complications
10/23/2024
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their experience with 2 distinct vascular closure device approaches using the Perclose ProGlide and the Angio-Seal, as well as the impact on vascular access site complications during transcatheter aortic valve...
The authors evaluated their...
10/23/2024
Journal of Invasive Cardiology
CABG
Black Patients More Likely to Die After Coronary Bypass Surgery
10/22/2024
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients, Black patients were 22% more likely to die in the hospital. Black patients stayed in the hospital 1.5 days longer on average (9.6 days for white patients, 10.7 days for Hispanic patients and 11.8 days for Black...
Compared to white patients,...
10/22/2024
Cath Lab Digest
Medaxiom survey
Cardiology Compensation and Production Reflect Post-Pandemic Changes to Provider Market
10/21/2024
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH, Fla. – MedAxiom, the premier source for cardiovascular organizational performance solutions, has released its 2024 Cardiovascular Provider Compensation and Production Survey Report that includes data from the...
MedAxiom News NEPTUNE BEACH,...
10/21/2024
Cath Lab Digest
Cardiology Innovations
Philips Showcases Next Level Cardiology Innovations for Improved Patient Care at TCT 2024
10/21/2024
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of image-guided therapy and echocardiography solutions uniquely integrates artificial intelligence into imaging systems and software, with specialized diagnostic and therapeutic devices to support exceptional treatment...
Philips portfolio of...
10/21/2024
Vascular Disease Management
Cardiovascular Risk After MI
Prolocor Announces Publication of Confirmatory Results From Multicenter 800 Patient Study in the Journal of the American College of Cardiology (JACC)
10/21/2024
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death&nbsp; Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold predictive value (p=0.001) for heart attack, stroke, and death&nbsp; Significant unmet need in balancing the risks and benefits of antithrombotic treatment in patients with acute coronary syndrome...
Greater than 2-fold...
10/21/2024
Vascular Disease Management
Pharmaceuticals
Acticor Biotech Repositions Glenzocimab in the Treatment of Myocardial Infarction
10/21/2024
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b, randomized and double-blind study will include more than 212 patients suffering from STEMI who are scheduled to undergo PCI. The study’s primary objective is to assess the safety and efficacy of glenzocimab 1000 mg...
The LIBERATE phase 2b,...
10/21/2024
Cath Lab Digest
PVD
Yale Study Finds Link Between Eczema and Peripheral Vascular Disease
10/21/2024
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred in 11% of patients with atopic dermatitis (AD), but just 6.2% of patients without AD.
The Yale team found PVD occurred...
10/21/2024
Cath Lab Digest

March 2003 Volume 15 Issue 5

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement